STAT3 and colorectal carcinoma: Other studies also demonstrate that bone marrow MSCs (bmMSCs) could remiss colitis-associated CRC by inhibiting the phosphorylation of STAT3 with resultant weight gain and reduced expressions of proinflammatory factors [79].